Vitiligo is an autoimmune depigment disease results from extensive melanocytes
destruction. The destruction of melanocyte is thought to be of multifactorial causation …

Vitiligo is a chronic autoimmune disease characterized by loss of pigment of the skin,
affecting 0.5–2% of the population worldwide. It can have a significant impact on patients' …

Background The treatment of vitiligo can be challenging and depends on several factors
such as the subtype, disease activity, vitiligo extent, and treatment goals. Vitiligo usually …

Background Vitiligo is a chronic autoimmune disorder characterized by depigmented
patches of the skin. Objective To evaluate the efficacy and safety of ritlecitinib, an oral JAK3 …

Background Vitamin E has long been linked to skin health, including all of its possible
functions in cosmetic products, to its roles in membrane integrity and even the aging …

Although senescence was originally described as an in vitro acquired cellular characteristic,
it was recently recognized that senescence is physiologically and pathologically involved in …

Introduction: Vitiligo is a relatively common autoimmune depigmenting disorder of the skin.
There has been a great advance in understanding the pathological basis, which has led to …

Alopecia areata (AA) and vitiligo are both common skin diseases of autoimmune origin. Both
alopecia areata and vitiligo have shown to be affected by oxidative stress. The present work …

Vitiligo, a common skin disease that seriously affects 0.5–2.0% of the worldwide population,
lacks approved therapeutics due to a wide range of adverse side effects. As a key regulator …

Background The pathogenesis of vitiligo remains a topic of extensive debate. This is partly
due to the moderate efficacy of current treatments. The role of the oxidative stress pathway in …